Purpose To study the anatomic and functional outcomes of Argus II Retinal Prosthesis
System implantation in patients with retinitis pigmentosa. Design Interventional case series …

Retinal prosthesis technologies require that the visual system downstream of the retinal
circuitry be capable of transmitting and elaborating visual signals. We studied the capability …

Purpose To report the outcome of 10 patients with optic pit maculopathy (OPM) and evaluate
the role of small-gauge vitrectomy, gas endotamponade, and additional laser …

Importance The postoperative retinal changes at the interface between an implant electrode
array and the retina and whether these anatomic changes have an association with the …

Purpose: To analyze and provide an overview of the incidence, management, and
prevention of conjunctival erosion in Argus II clinical trial subjects and postapproval patients …

Dear Editor, Retinitis pigmentosa is a genetic disease that leads to a progressive outer
retinal degeneration. The Argus II Retinal Prosthesis System (Second Sight Medical …

Methods This study retrospectively analysed the data of all 244 implant procedures that took
place between June 2007 and November 2017 in the postapproval phase (mean implant …

Induction of PVD was difficult in the young patients. This surgical step was not more
complicated using small-gauge instrumentation with respect to 20-gauge instrumentation …

Materials and Methods This study describes a retrospective consecutive series of 13 eyes of
13 patients, 4 women and 9 men, who underwent through pars plana vitrectomy (VPP) and …

Abstract The Argus® II surgical implantation is performed under general anesthesia with an
average duration of 3 h. Both standard vitreoretinal tools and specifically designed surgical …